Dr Craig Gedye (BSc(Hons), MBChB, FRACP, PhD) Senior Staff Specialist, Director, HMRI Clinical Trials, Clinical Research Director (NSW Statewide Biobank)
Dr Craig Gedye is a medical oncologist and cancer researcher. He works for people with melanoma, brain, prostate, bladder and kidney cancers at Calvary Mater Newcastle, and is the Director of the Hunter Medical Research Institute (HMRI) Clinical Trials Unit, and the Clinical Research Director at the NSW Health Statewide Biobank.
Dr Gedye’s focus is on complexity and heterogeneity in cancer. Why are cancers different between different people? Why are cancers cells different to each other? What does this mean for each person’s treatment? This challenging problem spans projects across the research spectrum, from patient experience, through clinical trials, translational biomarkers and questions in basic science.
Dr Gedye has the privilege of leading several national cancer clinical trials for the ANZUP and COGNO cancer trials groups, he is the chair for the ANZUP Renal Cancer Subcommittee, and is a member of the Scientific Advisory Committee for the Mark Hughes Foundation, COGNO Trials and ANZUP Cancer Trials Groups.
Kidney cancer, prostate cancer, brain cancer, clinical trials, melanoma, bladder cancer, drug repurposing, patient experience and outcome
Publications / Achievements
Dr Gedye works with the Calvary Mater Newcastle Medical Oncology Research Clinical Trials team on a large number of clinical trials. Many of these enable the testing of new ideas from commercial partners, but equally include clinical trials cooperating with doctors across Australia, and have recently started creating their own clinical trials.
Some of the clinical trials that have been developed include trials seeking to test new immunotherapy drugs in people with rare cancers of the kidney; a clinical trial testing if a safe, well-known treatment for osteoporosis can improve cancer immunotherapy, a study to look at the effects of immediate exercise in men with prostate cancer, and two trials that ask if spreading cancer treatment out over longer periods of time improves the outcomes of men with prostate cancer. The clinical trials team have several other trials in planning and development, focusing on brain cancer and other cancers.
More information about Dr Craig Gedye academic achievements and publications can be found here: